Yukifusa Igeta

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

Mitsuyasu Kanai, E. Matsubara, Kenji Isoe et al. · Annals of Neurology · 1998 · 342 citations

Medicine, Neurology, Neuroscience +17

Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease

Mikio Shoji, Etsuro Matsubara, Mitsuyasu Kanai et al. · Journal of the Neurological Sciences · 1998 · 222 citations

Life Sciences, Neurology, Neuroscience +16

A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: Description of clinical features and implications for genotype–phenotype correlations

Akatsuki Kubota, Ayumi Hida, Yaeko Ichikawa et al. · Movement Disorders · 2009 · 71 citations

Life Sciences, Genetics, Neurology +15

Modified Amyloid β Protein Ending at 42 or 40 with Different Solubility Accumulates in the Brain of Alzheimer′s Disease

Y Harigaya, Mikio Shoji, Takeshi Kawarabayashi et al. · Biochemical and Biophysical Research Communications · 1995 · 47 citations

Life Sciences, Biochemistry, Neuroscience +16

Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer’s disease pathogenesis

Kohei Yuyama, Hui Sun, Risa Fujii et al. · Brain · 2023 · 44 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17